10:51 AM EST - RepliCel Life Sciences Inc. : Has recently received notifications of several patents issued, allowed, and granted to the Company from Europe, China, Hong Kong, Japan, the United States and South Africa. These relate to three of the distinct patent families RepliCel continues to prosecute around the world. RepliCel Life Sciences Inc.
shares V.RP are trading up $0.025 at $0.33.
